Symplmed Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SYMPLMED PHARMS LLC, and what generic and branded alternatives to SYMPLMED PHARMS LLC drugs are available?
SYMPLMED PHARMS LLC has one approved drug.
Drugs and US Patents for Symplmed Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Symplmed Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | 4,508,729 | ⤷ Try a Trial |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | 5,162,362 | ⤷ Try a Trial |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | 5,162,362 | ⤷ Try a Trial |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | 4,508,729 | ⤷ Try a Trial |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | 5,162,362 | ⤷ Try a Trial |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | 4,508,729 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SYMPLMED PHARMS LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 2 mg, 4 mg and 8 mg | ➤ Subscribe | 2006-06-06 |
Similar Applicant Names
Here is a list of applicants with similar names.